866-997-4948(US-Canada Toll Free)

Asia-Pacific Drugs for Osteoarthritis Pain Market Report 2017

Published By :

QYResearch

Published Date : Jun 2017

Category :

Pharmaceutical

No. of Pages : 120 Pages

In this report, the Asia-Pacific Drugs for Osteoarthritis Pain market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Drugs for Osteoarthritis Pain for these regions, from 2012 to 2022 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Drugs for Osteoarthritis Pain market competition by top manufacturers/players, with Drugs for Osteoarthritis Pain sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Abbott Laboratories
Johnson & Johnson
Novartis International
Pfizer
AbbVie
Abiogen Pharma
Afferent Pharmaceuticals
Astellas Pharma
BioDelivery Sciences International
Crystal Genomics
Cytori Therapeutics
Daiichi Sankyo
Eli Lilly
Endo Pharmaceuticals Holdings
Horizon Pharma
iCeutica
Iroko Pharmaceuticals
Merck
Nuvo Research
Regeneron Pharmaceuticals
Sanofi
SantoSolve
Techfields Pharma
Winston Pharmaceuticals
Yooyoung Pharmaceutical
Zynerba Pharmaceuticals

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
Solid
Liquid
Semi-solid

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Drugs for Osteoarthritis Pain for each application, includin
Oral
Injection
External

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Asia-Pacific Drugs for Osteoarthritis Pain Market Report 2017
1 Drugs for Osteoarthritis Pain Overview
1.1 Product Overview and Scope of Drugs for Osteoarthritis Pain
1.2 Classification of Drugs for Osteoarthritis Pain by Product Category
1.2.1 Asia-Pacific Drugs for Osteoarthritis Pain Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific Drugs for Osteoarthritis Pain Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Solid
1.2.4 Liquid
1.2.5 Semi-solid
1.3 Asia-Pacific Drugs for Osteoarthritis Pain Market by Application/End Users
1.3.1 Asia-Pacific Drugs for Osteoarthritis Pain Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Oral
1.3.3 Injection
1.3.4 External
1.4 Asia-Pacific Drugs for Osteoarthritis Pain Market by Region
1.4.1 Asia-Pacific Drugs for Osteoarthritis Pain Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Drugs for Osteoarthritis Pain (2012-2022)
1.5.1 Asia-Pacific Drugs for Osteoarthritis Pain Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Drugs for Osteoarthritis Pain Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Drugs for Osteoarthritis Pain Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Drugs for Osteoarthritis Pain Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific Drugs for Osteoarthritis Pain Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Drugs for Osteoarthritis Pain (Volume and Value) by Type
2.2.1 Asia-Pacific Drugs for Osteoarthritis Pain Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Drugs for Osteoarthritis Pain (Volume) by Application
2.4 Asia-Pacific Drugs for Osteoarthritis Pain (Volume and Value) by Region
2.4.1 Asia-Pacific Drugs for Osteoarthritis Pain Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific Drugs for Osteoarthritis Pain Revenue and Market Share by Region (2012-2017)

3 China Drugs for Osteoarthritis Pain (Volume, Value and Sales Price)
3.1 China Drugs for Osteoarthritis Pain Sales and Value (2012-2017)
3.1.1 China Drugs for Osteoarthritis Pain Sales Volume and Growth Rate (2012-2017)
3.1.2 China Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2017)
3.1.3 China Drugs for Osteoarthritis Pain Sales Price Trend (2012-2017)
3.2 China Drugs for Osteoarthritis Pain Sales Volume and Market Share by Type
3.3 China Drugs for Osteoarthritis Pain Sales Volume and Market Share by Application

4 Japan Drugs for Osteoarthritis Pain (Volume, Value and Sales Price)
4.1 Japan Drugs for Osteoarthritis Pain Sales and Value (2012-2017)
4.1.1 Japan Drugs for Osteoarthritis Pain Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2017)
4.1.3 Japan Drugs for Osteoarthritis Pain Sales Price Trend (2012-2017)
4.2 Japan Drugs for Osteoarthritis Pain Sales Volume and Market Share by Type
4.3 Japan Drugs for Osteoarthritis Pain Sales Volume and Market Share by Application

5 South Korea Drugs for Osteoarthritis Pain (Volume, Value and Sales Price)
5.1 South Korea Drugs for Osteoarthritis Pain Sales and Value (2012-2017)
5.1.1 South Korea Drugs for Osteoarthritis Pain Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2017)
5.1.3 South Korea Drugs for Osteoarthritis Pain Sales Price Trend (2012-2017)
5.2 South Korea Drugs for Osteoarthritis Pain Sales Volume and Market Share by Type
5.3 South Korea Drugs for Osteoarthritis Pain Sales Volume and Market Share by Application

6 Taiwan Drugs for Osteoarthritis Pain (Volume, Value and Sales Price)
6.1 Taiwan Drugs for Osteoarthritis Pain Sales and Value (2012-2017)
6.1.1 Taiwan Drugs for Osteoarthritis Pain Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan Drugs for Osteoarthritis Pain Sales Price Trend (2012-2017)
6.2 Taiwan Drugs for Osteoarthritis Pain Sales Volume and Market Share by Type
6.3 Taiwan Drugs for Osteoarthritis Pain Sales Volume and Market Share by Application

7 India Drugs for Osteoarthritis Pain (Volume, Value and Sales Price)
7.1 India Drugs for Osteoarthritis Pain Sales and Value (2012-2017)
7.1.1 India Drugs for Osteoarthritis Pain Sales Volume and Growth Rate (2012-2017)
7.1.2 India Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2017)
7.1.3 India Drugs for Osteoarthritis Pain Sales Price Trend (2012-2017)
7.2 India Drugs for Osteoarthritis Pain Sales Volume and Market Share by Type
7.3 India Drugs for Osteoarthritis Pain Sales Volume and Market Share by Application

8 Southeast Asia Drugs for Osteoarthritis Pain (Volume, Value and Sales Price)
8.1 Southeast Asia Drugs for Osteoarthritis Pain Sales and Value (2012-2017)
8.1.1 Southeast Asia Drugs for Osteoarthritis Pain Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia Drugs for Osteoarthritis Pain Sales Price Trend (2012-2017)
8.2 Southeast Asia Drugs for Osteoarthritis Pain Sales Volume and Market Share by Type
8.3 Southeast Asia Drugs for Osteoarthritis Pain Sales Volume and Market Share by Application

9 Australia Drugs for Osteoarthritis Pain (Volume, Value and Sales Price)
9.1 Australia Drugs for Osteoarthritis Pain Sales and Value (2012-2017)
9.1.1 Australia Drugs for Osteoarthritis Pain Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2017)
9.1.3 Australia Drugs for Osteoarthritis Pain Sales Price Trend (2012-2017)
9.2 Australia Drugs for Osteoarthritis Pain Sales Volume and Market Share by Type
9.3 Australia Drugs for Osteoarthritis Pain Sales Volume and Market Share by Application

10 Asia-Pacific Drugs for Osteoarthritis Pain Players/Suppliers Profiles and Sales Data
10.1 Abbott Laboratories
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Abbott Laboratories Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Johnson & Johnson
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Novartis International
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Novartis International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Pfizer
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Pfizer Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 AbbVie
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 AbbVie Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Abiogen Pharma
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Abiogen Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Afferent Pharmaceuticals
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Astellas Pharma
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Astellas Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 BioDelivery Sciences International
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Crystal Genomics
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Crystal Genomics Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Cytori Therapeutics
10.12 Daiichi Sankyo
10.13 Eli Lilly
10.14 Endo Pharmaceuticals Holdings
10.15 Horizon Pharma
10.16 iCeutica
10.17 Iroko Pharmaceuticals
10.18 Merck
10.19 Nuvo Research
10.20 Regeneron Pharmaceuticals
10.21 Sanofi
10.22 SantoSolve
10.23 Techfields Pharma
10.24 Winston Pharmaceuticals
10.25 Yooyoung Pharmaceutical
10.26 Zynerba Pharmaceuticals

11 Drugs for Osteoarthritis Pain Manufacturing Cost Analysis
11.1 Drugs for Osteoarthritis Pain Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Drugs for Osteoarthritis Pain

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Drugs for Osteoarthritis Pain Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Drugs for Osteoarthritis Pain Major Manufacturers in 2016
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific Drugs for Osteoarthritis Pain Market Forecast (2017-2022)
15.1 Asia-Pacific Drugs for Osteoarthritis Pain Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific Drugs for Osteoarthritis Pain Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific Drugs for Osteoarthritis Pain Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Drugs for Osteoarthritis Pain Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific Drugs for Osteoarthritis Pain Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China Drugs for Osteoarthritis Pain Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan Drugs for Osteoarthritis Pain Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea Drugs for Osteoarthritis Pain Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan Drugs for Osteoarthritis Pain Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India Drugs for Osteoarthritis Pain Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia Drugs for Osteoarthritis Pain Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia Drugs for Osteoarthritis Pain Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Drugs for Osteoarthritis Pain Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific Drugs for Osteoarthritis Pain Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific Drugs for Osteoarthritis Pain Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific Drugs for Osteoarthritis Pain Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Drugs for Osteoarthritis Pain Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Drugs for Osteoarthritis Pain
Figure Asia-Pacific Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Type (2012-2022)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (Product Category) in 2016
Figure Solid Product Picture
Figure Liquid Product Picture
Figure Semi-solid Product Picture
Figure Asia-Pacific Drugs for Osteoarthritis Pain Sales (K Pcs) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Drugs for Osteoarthritis Pain by Application in 2016
Figure Oral Examples
Figure Injection Examples
Figure External Examples
Figure Asia-Pacific Drugs for Osteoarthritis Pain Market Size (Million USD) by Region (2012-2022)
Figure China Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Market Major Players Product Sales Volume (K Pcs)(2012-2017)
Table Asia-Pacific Drugs for Osteoarthritis Pain Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Drugs for Osteoarthritis Pain Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Drugs for Osteoarthritis Pain Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Drugs for Osteoarthritis Pain Sales Share by Players/Suppliers
Figure Asia-Pacific Drugs for Osteoarthritis Pain Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Drugs for Osteoarthritis Pain Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Drugs for Osteoarthritis Pain Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Drugs for Osteoarthritis Pain Revenue Share by Players
Figure 2017 Asia-Pacific Drugs for Osteoarthritis Pain Revenue Share by Players
Table Asia-Pacific Drugs for Osteoarthritis Pain Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Drugs for Osteoarthritis Pain Sales Share by Type (2012-2017)
Figure Sales Market Share of Drugs for Osteoarthritis Pain by Type (2012-2017)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Drugs for Osteoarthritis Pain Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Drugs for Osteoarthritis Pain Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Drugs for Osteoarthritis Pain by Type (2012-2017)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Asia-Pacific Drugs for Osteoarthritis Pain Sales Share by Region (2012-2017)
Figure Sales Market Share of Drugs for Osteoarthritis Pain by Region (2012-2017)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Sales Market Share by Region in 2016
Table Asia-Pacific Drugs for Osteoarthritis Pain Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Drugs for Osteoarthritis Pain Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Drugs for Osteoarthritis Pain by Region (2012-2017)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Share by Region in 2016
Table Asia-Pacific Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Asia-Pacific Drugs for Osteoarthritis Pain Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Sales Market Share by Application (2012-2017)
Figure China Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Drugs for Osteoarthritis Pain Sales Price (USD/Pcs) Trend (2012-2017)
Table China Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Type (2012-2017)
Table China Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (2012-2017)
Figure China Drugs for Osteoarthritis Pain Sales Volume Market Share by Type in 2016
Table China Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Applications (2012-2017)
Table China Drugs for Osteoarthritis Pain Sales Volume Market Share by Application (2012-2017)
Figure China Drugs for Osteoarthritis Pain Sales Volume Market Share by Application in 2016
Figure Japan Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Drugs for Osteoarthritis Pain Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (2012-2017)
Figure Japan Drugs for Osteoarthritis Pain Sales Volume Market Share by Type in 2016
Table Japan Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Applications (2012-2017)
Table Japan Drugs for Osteoarthritis Pain Sales Volume Market Share by Application (2012-2017)
Figure Japan Drugs for Osteoarthritis Pain Sales Volume Market Share by Application in 2016
Figure South Korea Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure South Korea Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Drugs for Osteoarthritis Pain Sales Price (USD/Pcs) Trend (2012-2017)
Table South Korea Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Type (2012-2017)
Table South Korea Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (2012-2017)
Figure South Korea Drugs for Osteoarthritis Pain Sales Volume Market Share by Type in 2016
Table South Korea Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Applications (2012-2017)
Table South Korea Drugs for Osteoarthritis Pain Sales Volume Market Share by Application (2012-2017)
Figure South Korea Drugs for Osteoarthritis Pain Sales Volume Market Share by Application in 2016
Figure Taiwan Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure Taiwan Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Drugs for Osteoarthritis Pain Sales Price (USD/Pcs) Trend (2012-2017)
Table Taiwan Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Type (2012-2017)
Table Taiwan Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Drugs for Osteoarthritis Pain Sales Volume Market Share by Type in 2016
Table Taiwan Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Applications (2012-2017)
Table Taiwan Drugs for Osteoarthritis Pain Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Drugs for Osteoarthritis Pain Sales Volume Market Share by Application in 2016
Figure India Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Drugs for Osteoarthritis Pain Sales Price (USD/Pcs) Trend (2012-2017)
Table India Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Type (2012-2017)
Table India Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (2012-2017)
Figure India Drugs for Osteoarthritis Pain Sales Volume Market Share by Type in 2016
Table India Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Application (2012-2017)
Table India Drugs for Osteoarthritis Pain Sales Volume Market Share by Application (2012-2017)
Figure India Drugs for Osteoarthritis Pain Sales Volume Market Share by Application in 2016
Figure Southeast Asia Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Drugs for Osteoarthritis Pain Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Drugs for Osteoarthritis Pain Sales Volume Market Share by Type in 2016
Table Southeast Asia Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Applications (2012-2017)
Table Southeast Asia Drugs for Osteoarthritis Pain Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Drugs for Osteoarthritis Pain Sales Volume Market Share by Application in 2016
Figure Australia Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure Australia Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Drugs for Osteoarthritis Pain Sales Price (USD/Pcs) Trend (2012-2017)
Table Australia Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Type (2012-2017)
Table Australia Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (2012-2017)
Figure Australia Drugs for Osteoarthritis Pain Sales Volume Market Share by Type in 2016
Table Australia Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Applications (2012-2017)
Table Australia Drugs for Osteoarthritis Pain Sales Volume Market Share by Application (2012-2017)
Figure Australia Drugs for Osteoarthritis Pain Sales Volume Market Share by Application in 2016
Table Abbott Laboratories Drugs for Osteoarthritis Pain Basic Information List
Table Abbott Laboratories Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Laboratories Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure Abbott Laboratories Drugs for Osteoarthritis Pain Sales Market Share in Asia-Pacific (2012-2017)
Figure Abbott Laboratories Drugs for Osteoarthritis Pain Revenue Market Share in Asia-Pacific (2012-2017)
Table Johnson & Johnson Drugs for Osteoarthritis Pain Basic Information List
Table Johnson & Johnson Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure Johnson & Johnson Drugs for Osteoarthritis Pain Sales Market Share in Asia-Pacific (2012-2017)
Figure Johnson & Johnson Drugs for Osteoarthritis Pain Revenue Market Share in Asia-Pacific (2012-2017)
Table Novartis International Drugs for Osteoarthritis Pain Basic Information List
Table Novartis International Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis International Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure Novartis International Drugs for Osteoarthritis Pain Sales Market Share in Asia-Pacific (2012-2017)
Figure Novartis International Drugs for Osteoarthritis Pain Revenue Market Share in Asia-Pacific (2012-2017)
Table Pfizer Drugs for Osteoarthritis Pain Basic Information List
Table Pfizer Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Drugs for Osteoarthritis Pain Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer Drugs for Osteoarthritis Pain Revenue Market Share in Asia-Pacific (2012-2017)
Table AbbVie Drugs for Osteoarthritis Pain Basic Information List
Table AbbVie Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure AbbVie Drugs for Osteoarthritis Pain Sales Market Share in Asia-Pacific (2012-2017)
Figure AbbVie Drugs for Osteoarthritis Pain Revenue Market Share in Asia-Pacific (2012-2017)
Table Abiogen Pharma Drugs for Osteoarthritis Pain Basic Information List
Table Abiogen Pharma Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abiogen Pharma Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure Abiogen Pharma Drugs for Osteoarthritis Pain Sales Market Share in Asia-Pacific (2012-2017)
Figure Abiogen Pharma Drugs for Osteoarthritis Pain Revenue Market Share in Asia-Pacific (2012-2017)
Table Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Basic Information List
Table Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales Market Share in Asia-Pacific (2012-2017)
Figure Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Revenue Market Share in Asia-Pacific (2012-2017)
Table Astellas Pharma Drugs for Osteoarthritis Pain Basic Information List
Table Astellas Pharma Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Astellas Pharma Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure Astellas Pharma Drugs for Osteoarthritis Pain Sales Market Share in Asia-Pacific (2012-2017)
Figure Astellas Pharma Drugs for Osteoarthritis Pain Revenue Market Share in Asia-Pacific (2012-2017)
Table BioDelivery Sciences International Drugs for Osteoarthritis Pain Basic Information List
Table BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales Market Share in Asia-Pacific (2012-2017)
Figure BioDelivery Sciences International Drugs for Osteoarthritis Pain Revenue Market Share in Asia-Pacific (2012-2017)
Table Crystal Genomics Drugs for Osteoarthritis Pain Basic Information List
Table Crystal Genomics Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Crystal Genomics Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure Crystal Genomics Drugs for Osteoarthritis Pain Sales Market Share in Asia-Pacific (2012-2017)
Figure Crystal Genomics Drugs for Osteoarthritis Pain Revenue Market Share in Asia-Pacific (2012-2017)
Table Cytori Therapeutics Drugs for Osteoarthritis Pain Basic Information List
Table Daiichi Sankyo Drugs for Osteoarthritis Pain Basic Information List
Table Eli Lilly Drugs for Osteoarthritis Pain Basic Information List
Table Endo Pharmaceuticals Holdings Drugs for Osteoarthritis Pain Basic Information List
Table Horizon Pharma Drugs for Osteoarthritis Pain Basic Information List
Table iCeutica Drugs for Osteoarthritis Pain Basic Information List
Table Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Basic Information List
Table Merck Drugs for Osteoarthritis Pain Basic Information List
Table Nuvo Research Drugs for Osteoarthritis Pain Basic Information List
Table Regeneron Pharmaceuticals Drugs for Osteoarthritis Pain Basic Information List
Table Sanofi Drugs for Osteoarthritis Pain Basic Information List
Table SantoSolve Drugs for Osteoarthritis Pain Basic Information List
Table Techfields Pharma Drugs for Osteoarthritis Pain Basic Information List
Table Winston Pharmaceuticals Drugs for Osteoarthritis Pain Basic Information List
Table Yooyoung Pharmaceutical Drugs for Osteoarthritis Pain Basic Information List
Table Zynerba Pharmaceuticals Drugs for Osteoarthritis Pain Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Pcs) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Osteoarthritis Pain
Figure Manufacturing Process Analysis of Drugs for Osteoarthritis Pain
Figure Drugs for Osteoarthritis Pain Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Osteoarthritis Pain Major Manufacturers in 2016
Table Major Buyers of Drugs for Osteoarthritis Pain
Table Distributors/Traders List
Figure Asia-Pacific Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Asia-Pacific Drugs for Osteoarthritis Pain Sales Volume (K Pcs) Forecast by Region (2017-2022)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Drugs for Osteoarthritis Pain Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Share Forecast by Region in 2022
Figure China Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure South Korea Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Taiwan Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Australia Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Drugs for Osteoarthritis Pain Sales (K Pcs) Forecast by Type (2017-2022)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Drugs for Osteoarthritis Pain Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Drugs for Osteoarthritis Pain Price (USD/Pcs) Forecast by Type (2017-2022)
Table Asia-Pacific Drugs for Osteoarthritis Pain Sales (K Pcs) Forecast by Application (2017-2022)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *